For example, the transmembrane glycoprotein CD44 was up-regulated in tamoxifen-resistant breast cancer cells and enhanced their sensitivity to ErbB ligands and hyaluronan, thus promoting an adverse phenotype (51). This evidence concerns the gene EGFR and breast carcinoma.